# Nerveblocks for Persistent Pain After Breast Cancer Surgery

> **NCT02336529** · PHASE3 · UNKNOWN · sponsor: **Kenneth Geving Andersen** · enrollment: 48 (estimated)

## Conditions studied

- Pain
- Neuropathic Pain
- Breast Cancer

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** NaCl

## Key facts

- **NCT ID:** NCT02336529
- **Lead sponsor:** Kenneth Geving Andersen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2015-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336529, "Nerveblocks for Persistent Pain After Breast Cancer Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02336529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*